Related Experiment Videos
Palliative pelvic exenteration--futility revisited.
Gynecologic Oncology
|May 1, 1987
Summary
Palliative pelvic exenteration offers poor outcomes for cancer patients. This surgery resulted in high morbidity, mortality, low survival, and uniformly poor quality of life, suggesting it should be avoided.
Area of Science:
- Oncology
- Surgical Oncology
- Palliative Care
Background:
- Pelvic exenteration is a radical surgical procedure for advanced pelvic cancers.
- The role of palliative pelvic exenteration in cases with metastatic disease is controversial.
Purpose of the Study:
- To evaluate the outcomes of palliative pelvic exenteration in patients with advanced pelvic malignancies.
- To determine the impact of palliative exenteration on morbidity, mortality, survival, and quality of life.
Main Methods:
- A retrospective review of 23 pelvic exenterations performed at Miami Valley Hospital.
- Analysis of 8 procedures identified as palliative due to specific metastatic criteria (lymph node, peritoneal, sidewall, or distant spread).
Main Results:
- Palliative pelvic exenteration was associated with high rates of morbidity and mortality.
- Patients undergoing palliative exenteration experienced low survival rates.
- Quality of life was uniformly poor in all patients who underwent palliative exenteration.
Conclusions:
- Pelvic exenteration performed for palliative reasons in the presence of advanced metastatic disease leads to poor patient outcomes.
- The risks and low benefits suggest that deliberate palliative pelvic exenteration should generally be avoided.
- Careful patient selection and consideration of alternative palliative strategies are crucial.